Journal article
Which Factors Influence Resident Physicians to Prescribe NOACs to Patients with Non-Valvular Atrial Fibrillation?
Abstract
The Canadian Cardiovascular Society and the European Society of Cardiology recommend the use of non-vitamin K antagonists (NOAC) in preference to warfarin for stroke prevention in most patients with non-valvular atrial fibrillation (AF). The aim of this study was to identify factors that predict selection of a NOAC by resident physicians when faced with patients with non-valvular AF. A web-based survey was distributed to residents across Canada …
Authors
Oqab Z; McIntyre WF; Hopman WM; Baranchuk A
Journal
Journal of Atrial Fibrillation and Electrophysiology, Vol. 9, No. 2,
DOI
10.4022/jafib.1462
ISSN
1941-6911